{"id":"https://openalex.org/W7196923348","doi":"https://doi.org/10.1007/s00262-026-04589-4","title":"Neoadjuvant durvalumab and tremelimumab in combination with chemotherapy in newly diagnosed advanced high-grade serous ovarian cancer (iPRIME): a randomized, non-comparative phase 2 trial using chemotherapy response score as the primary endpoint","display_name":"Neoadjuvant durvalumab and tremelimumab in combination with chemotherapy in newly diagnosed advanced high-grade serous ovarian cancer (iPRIME): a randomized, non-comparative phase 2 trial using chemotherapy response score as the primary endpoint","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7196923348","doi":"https://doi.org/10.1007/s00262-026-04589-4"},"language":"en","primary_location":{"id":"doi:10.1007/s00262-026-04589-4","doi":"https://doi.org/10.1007/s00262-026-04589-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-026-04589-4","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s00262-026-04589-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073719611","display_name":"Tarek M. Meniawy","orcid":"https://orcid.org/0000-0002-1457-6137","observed_orcids":["https://orcid.org/0000-0002-1457-6137"]},"institutions":[{"id":"https://openalex.org/I1292109108","display_name":"St John of God Subiaco Hospital","ror":"https://ror.org/00hvh1x59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1292109108"]},{"id":"https://openalex.org/I4210156497","display_name":"Linear Clinical Research","ror":"https://ror.org/05vnpr825","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210156497"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Tarek Meniawy","raw_affiliation_strings":["John of God Hospital, Subiaco, WA, Australia","Linear Clinical Research, Nedlands, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John of God Hospital, Subiaco, WA, Australia","institution_ids":["https://openalex.org/I1292109108"]},{"raw_affiliation_string":"Linear Clinical Research, Nedlands, Australia","institution_ids":["https://openalex.org/I4210156497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008937610","display_name":"Janine Margaret Lombard","orcid":"https://orcid.org/0000-0002-9551-0542","observed_orcids":["https://orcid.org/0000-0002-9551-0542"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janine Lombard","raw_affiliation_strings":["Newcastle Private Hospital, Newcastle, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Newcastle Private Hospital, Newcastle, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029807906","display_name":"Catherine Shannon","orcid":"https://orcid.org/0000-0002-2078-2869","observed_orcids":["https://orcid.org/0000-0002-2078-2869"]},"institutions":[{"id":"https://openalex.org/I4210161304","display_name":"Mater Adult Hospital","ror":"https://ror.org/05wqhv079","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1316052090","https://openalex.org/I4210161304"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Catherine Shannon","raw_affiliation_strings":["Mater Adult Hospital, South Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mater Adult Hospital, South Brisbane, Australia","institution_ids":["https://openalex.org/I4210161304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063000325","display_name":"Linda Mileshkin","orcid":"https://orcid.org/0000-0001-6826-6014","observed_orcids":["https://orcid.org/0000-0001-6826-6014"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Linda Mileshkin","raw_affiliation_strings":["Peter MacCallum Cancer Centre, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre, Melbourne, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018801649","display_name":"Jeffrey C.H. Goh","orcid":"https://orcid.org/0000-0002-1681-0484","observed_orcids":["https://orcid.org/0000-0002-1681-0484","https://orcid.org/0000-0003-3103-146X"]},"institutions":[{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jeffrey Goh","raw_affiliation_strings":["Royal Brisbane and Women\u2019s Hospital, Herston, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Brisbane and Women\u2019s Hospital, Herston, Australia","institution_ids":["https://openalex.org/I2799393793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137172102","display_name":"Bo Gao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Bo Gao","raw_affiliation_strings":["Westmead Hospital, Westmead, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Westmead Hospital, Westmead, Australia","institution_ids":["https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035525899","display_name":"Kate Webber","orcid":"https://orcid.org/0000-0003-4350-0884","observed_orcids":["https://orcid.org/0000-0003-4350-0884"]},"institutions":[{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kate Webber","raw_affiliation_strings":["Monash Health, Clayton, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash Health, Clayton, Australia","institution_ids":["https://openalex.org/I4210121067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068373651","display_name":"Navin David Palayoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292109108","display_name":"St John of God Subiaco Hospital","ror":"https://ror.org/00hvh1x59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1292109108"]},{"id":"https://openalex.org/I4210156497","display_name":"Linear Clinical Research","ror":"https://ror.org/05vnpr825","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210156497"]},{"id":"https://openalex.org/I4210160284","display_name":"Australia New Zealand Gynaecological Oncology Group","ror":"https://ror.org/0552kvw18","country_code":"AU","type":"other","lineage":["https://openalex.org/I4210160284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Navin David Palayoor","raw_affiliation_strings":["Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia","John of God Hospital, Subiaco, WA, Australia","Linear Clinical Research, Nedlands, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia","institution_ids":["https://openalex.org/I4210160284"]},{"raw_affiliation_string":"John of God Hospital, Subiaco, WA, Australia","institution_ids":["https://openalex.org/I1292109108"]},{"raw_affiliation_string":"Linear Clinical Research, Nedlands, Australia","institution_ids":["https://openalex.org/I4210156497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010637706","display_name":"Colin J.R. Stewart","orcid":"https://orcid.org/0000-0002-2165-464X","observed_orcids":["https://orcid.org/0000-0002-2165-464X"]},"institutions":[{"id":"https://openalex.org/I2801351171","display_name":"King Edward Memorial Hospital","ror":"https://ror.org/00ns3e792","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801351171"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Colin Stewart","raw_affiliation_strings":["Department of Pathology, King Edward Memorial Hospital, Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, King Edward Memorial Hospital, Perth, Australia","institution_ids":["https://openalex.org/I2801351171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135253934","display_name":"Michael C. Fahey","orcid":"https://orcid.org/0000-0003-0811-4785","observed_orcids":["https://orcid.org/0000-0003-0811-4785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael T. Fahey","raw_affiliation_strings":["Centre for Biostatistics and Clinical Trials (BaCT), Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Biostatistics and Clinical Trials (BaCT), Melbourne, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093222953","display_name":"Petra Opar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petra Opar","raw_affiliation_strings":["Centre for Biostatistics and Clinical Trials (BaCT), Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Biostatistics and Clinical Trials (BaCT), Melbourne, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102520584","display_name":"John Andrews","orcid":"https://orcid.org/0000-0003-0228-4695","observed_orcids":["https://orcid.org/0000-0003-0228-4695"]},"institutions":[{"id":"https://openalex.org/I4210160284","display_name":"Australia New Zealand Gynaecological Oncology Group","ror":"https://ror.org/0552kvw18","country_code":"AU","type":"other","lineage":["https://openalex.org/I4210160284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John Andrews","raw_affiliation_strings":["Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia","institution_ids":["https://openalex.org/I4210160284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5145118920","display_name":"Kate Weatherall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160284","display_name":"Australia New Zealand Gynaecological Oncology Group","ror":"https://ror.org/0552kvw18","country_code":"AU","type":"other","lineage":["https://openalex.org/I4210160284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kate Weatherall","raw_affiliation_strings":["Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia","institution_ids":["https://openalex.org/I4210160284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050644191","display_name":"Marilyn Boo","orcid":"https://orcid.org/0000-0002-1374-8507","observed_orcids":["https://orcid.org/0000-0002-1374-8507"]},"institutions":[{"id":"https://openalex.org/I4210160284","display_name":"Australia New Zealand Gynaecological Oncology Group","ror":"https://ror.org/0552kvw18","country_code":"AU","type":"other","lineage":["https://openalex.org/I4210160284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Marilyn Boo","raw_affiliation_strings":["Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia"],"raw_orcid":"https://orcid.org/0000-0002-1374-8507","affiliations":[{"raw_affiliation_string":"Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, Australia","institution_ids":["https://openalex.org/I4210160284"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021894535","display_name":"Michael Leonard Friedlander","orcid":"https://orcid.org/0000-0003-3090-795X","observed_orcids":["https://orcid.org/0000-0003-3090-795X"]},"institutions":[{"id":"https://openalex.org/I2799851941","display_name":"Royal Hospital for Women","ror":"https://ror.org/021cxfs56","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799851941","https://openalex.org/I4210147382"]},{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael Friedlander","raw_affiliation_strings":["Prince of Wales Hospital and Royal Hospital for Women Randwick, School of Clinical Medicine, Faculty of Medicine and Health, University of New South, Sydney, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prince of Wales Hospital and Royal Hospital for Women Randwick, School of Clinical Medicine, Faculty of Medicine and Health, University of New South, Sydney, WA, Australia","institution_ids":["https://openalex.org/I2799851941","https://openalex.org/I31746571","https://openalex.org/I4210108821"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5073719611"],"corresponding_institution_ids":["https://openalex.org/I1292109108","https://openalex.org/I4210156497"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.57128226,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemotherapy-response-score","display_name":"chemotherapy response score","score":0.5550000071525574},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9509999752044678},{"id":"https://openalex.org/keywords/tremelimumab","display_name":"tremelimumab","score":1.0},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8859999775886536},{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.871999979019165},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7710000276565552},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8849999904632568},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.8140000104904175},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7549999952316284},{"id":"https://openalex.org/keywords/ca-125-response","display_name":"CA-125 response","score":0.8510000109672546},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.6700000166893005},{"id":"https://openalex.org/keywords/peritoneal-cancer","display_name":"peritoneal cancer","score":0.9150000214576721},{"id":"https://openalex.org/keywords/radiological-response","display_name":"radiological response","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C2778650287","wikidata":"https://www.wikidata.org/wiki/Q7838098","display_name":"Tremelimumab","level":5,"score":0.9408000111579895},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.8600999712944031},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8504999876022339},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8166999816894531},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6370000243186951},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6334999799728394},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6284000277519226},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5188000202178955},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.40880000591278076},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4081000089645386},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.35839998722076416},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.35269999504089355},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.3513000011444092},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.3441999852657318},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.32910001277923584},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.31290000677108765},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.30480000376701355},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.29989999532699585},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.2847999930381775},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.27730000019073486},{"id":"https://openalex.org/C2777407522","wikidata":"https://www.wikidata.org/wiki/Q1077603","display_name":"Mesothelioma","level":2,"score":0.2680000066757202},{"id":"https://openalex.org/C202953159","wikidata":"https://www.wikidata.org/wiki/Q382695","display_name":"Intention-to-treat analysis","level":3,"score":0.2619999945163727},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25760000944137573},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.2506999969482422}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1007/s00262-026-04589-4","doi":"https://doi.org/10.1007/s00262-026-04589-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-026-04589-4","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-10522632/v1","doi":"https://doi.org/10.21203/rs.3.rs-10522632/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-10522632/v1","pdf_url":"https://www.researchsquare.com/article/rs-10522632/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1007/s00262-026-04589-4","doi":"https://doi.org/10.1007/s00262-026-04589-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-026-04589-4","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7196923348.pdf","grobid_xml":"https://content.openalex.org/works/W7196923348.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1964736695","https://openalex.org/W2064205886","https://openalex.org/W2071069178","https://openalex.org/W2079537409","https://openalex.org/W2113122060","https://openalex.org/W2135947389","https://openalex.org/W2146967368","https://openalex.org/W2168893449","https://openalex.org/W2509217584","https://openalex.org/W2805354595","https://openalex.org/W2811088815","https://openalex.org/W2889646458","https://openalex.org/W2893960509","https://openalex.org/W2897430921","https://openalex.org/W2945550010","https://openalex.org/W2958203556","https://openalex.org/W2975141952","https://openalex.org/W2976139792","https://openalex.org/W2977392388","https://openalex.org/W2989861603","https://openalex.org/W2994977341","https://openalex.org/W3016085372","https://openalex.org/W3119959401","https://openalex.org/W3171517418","https://openalex.org/W3188131079","https://openalex.org/W3200231835","https://openalex.org/W4205306227","https://openalex.org/W4210971182","https://openalex.org/W4285992810","https://openalex.org/W4387849987","https://openalex.org/W4399380802","https://openalex.org/W4408165902","https://openalex.org/W4412003129","https://openalex.org/W7152972888"],"related_works":["https://openalex.org/W4282970659","https://openalex.org/W4408165902","https://openalex.org/W4387849987","https://openalex.org/W3196213437","https://openalex.org/W4290790619","https://openalex.org/W4386948474","https://openalex.org/W3172591831","https://openalex.org/W4399380802","https://openalex.org/W2946550606","https://openalex.org/W4372050323"],"abstract_inverted_index":{"Abstract":[0],"Objective":[1],"To":[2],"determine":[3],"the":[4,25,113,244,250,262,274],"efficacy":[5,246],"of":[6,35,128,140,181,265,276,290],"neoadjuvant":[7,88,239,277],"dual":[8,278],"immune":[9],"checkpoint":[10],"blockade":[11,279],"with":[12,18,62,81,103,220,281],"durvalumab":[13,76,235],"and":[14,20,66,77,83,90,122,236,287],"tremelimumab":[15,78,237],"in":[16,37,79,101,117,130,143,160,163,178,217,223,261,283],"combination":[17,80],"carboplatin":[19,82,89],"paclitaxel":[21,84,91],"(Du-T-NACT),":[22],"defined":[23],"by":[24,155,188,205],"chemotherapy":[26,135,282],"response":[27,136,185,204],"score":[28],"(CRS)":[29],"3":[30,99,115,142,153,256],"rate":[31,100,105,116,139,154],"after":[32,186],"three":[33],"cycles":[34],"treatment,":[36],"newly":[38],"diagnosed":[39],"advanced":[40,284],"stage":[41,64],"high-grade":[42],"serous":[43,70],"ovarian,":[44],"fallopian":[45],"tube":[46],"or":[47,86,227],"peritoneal":[48],"carcinoma.":[49],"Methods":[50],"iPRIME":[51],"is":[52,270],"an":[53],"open":[54],"label,":[55],"non-comparative":[56],"multicentre":[57],"phase":[58],"2":[59],"study.":[60],"Patients":[61],"FIGO":[63],"IIIC":[65],"IV":[67],"high":[68],"grade":[69],"carcinomawere":[71],"randomized":[72],"2:1":[73],"to":[74,238,253,272],"receive":[75],"(Du-T-NACT)":[85],"standard":[87],"alone":[92],"(NACT).":[93],"The":[94,138,151],"primary":[95,245,259],"endpoint":[96,260],"was":[97,145,158,175,191,202,214,249],"CRS":[98,114,141,152,255],"Du-T-NACT,":[102],"a":[104,258],"exceeding":[106],"50%":[107],"considered":[108],"positive.":[109],"Secondary":[110],"endpoints":[111],"included":[112],"each":[118],"arm,":[119],"progression-free":[120,212],"survival,":[121],"radiological":[123],"response.":[124,291],"Results":[125],"40/49":[126],"(81.6%)":[127],"patients":[129],"Du-T-NACT":[131,144,161],"were":[132],"evaluable":[133],"for":[134],"score.":[137],"13/40":[146],"(32%,":[147],"90%":[148],"CI":[149],"20\u201347%).":[150],"central":[156],"review":[157],"higher":[159],"than":[162],"NACT":[164],"(27%":[165],"[13/49]":[166],"versus":[167,196,209],"3.8%":[168],"[1/26],":[169],"p":[170,198],"=":[171,199,231],"0.03),":[172],"but":[173],"this":[174],"not":[176,242],"reflected":[177],"other":[179],"measures":[180],"clinical":[182],"benefit.":[183],"Radiological":[184],"treatment":[187,264],"RECIST":[189],"1.1":[190],"similar":[192],"between":[193],"arms":[194],"(45%":[195],"50%,":[197],"0.82),":[200],"as":[201,257],"CA-125":[203],"GCIG":[206],"criteria":[207],"(80%":[208],"81%).":[210],"Median":[211],"survival":[213],"14.7":[215],"months":[216,229],"both":[218],"arms,":[219],"no":[221],"difference":[222],"PFS":[224],"at":[225],"12":[226],"24":[228],"(p":[230],"0.64).":[232],"Conclusion":[233],"Combining":[234],"carboplatin\u2013paclitaxel":[240],"did":[241],"achieve":[243],"endpoint.":[247],"This":[248],"first":[251],"study":[252],"utilise":[254],"frontline":[263],"ovarian":[266,285],"cancer.":[267],"Further":[268],"research":[269],"required":[271],"assess":[273],"role":[275],"immunotherapy":[280],"cancer":[286],"identify":[288],"biomarkers":[289]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-07T00:00:00"}